Increasing Naloxone Co-prescription for Patients on Chronic Opioids: a Student-Led Initiative 1 1 1,2 1,2 Jonathan E. Freise, BS, MS , Elizabeth E. McCarthy, BS ,Michelle Guy,MD , Scott Steiger, MD , 1,2 and Leslie Sheu, MD 1 2 School of Medicine, University of California, San Francisco, San Francisco, CA, USA; Department of Medicine , University of California, San Francisco, San Francisco, CA, USA. KEY WORDS: naloxone; opioids; primary care; quality improvement; registry (N = 101), including each patient’s MED, naloxone medical education. co-prescription status, and a suggested script for discussing naloxone with patients based on previous recommendations J Gen Intern Med 33(6):797–8 DOI: 10.1007/s11606-018-4397-7 (Text Box). To address time burden, we provided medical © Society of General Internal Medicine 2018 assistants (MAs) with a list of patients on high-dose chronic opioids without a naloxone co-prescription and an upcoming clinic appointment every 2 weeks during the intervention INTRODUCTION period (October 2016–February 2017). MAs queued naloxone In 2016, the Center for Disease Control (CDC) established prescription orders in the electronic medical record (EMR) guidelines for primary care providers prescribing opioids for during the check-in process to serve as visual reminders for chronic pain, including naloxone co-prescription for patients providers to
Journal of General Internal Medicine – Springer Journals
Published: Mar 19, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera